Clinical Trial

Evaluation of Cardiovascular Risks Among the Participants of the ESC Congress 2025

Study acronym: ESC-CVRISK2025
Completed
View on ClinicalTrials.gov →
Summary
The European Society of Cardiology (ESC) is dedicated to promoting cardiovascular (CV) health and minimizing the occurrence of cardiovascular diseases throughout Europe. As a founding member of the European Alliance for Cardiovascular Health (EACH), the ESC is advocating for European and National Cardiovascular Health Plans which would include a cardiovascular and diabetes health check as part of a screening process for citizens. In line with this call for public health diagnosis of CV health, the ESC is committed to raising awareness on the need for actions and proposes to offer complimentary tests to delegates at ESC Congress 2025 in Madrid.
Trial Details
NCT Number NCT07613229
Lead Sponsor European Society of Cardiology
Conditions Cardiovascular Risk
Enrollment 1,366 participants
Start Date 2025-08-29
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-29